GE2P2 Global :: Knowledge Sharing; Ideas; Operations

Human Rights Action :: Humanitarian Response :: Health :: Education :: Heritage Stewardship :: Sustainable Development

Menu

Skip to content
  • Home
  • GE2P2 Global Foundation
    • RFI :: Project Documentation – Report Drafts/Final Versions et al
    • NYAS – Gene Therapies – Bioethics Challenges and Solutions – 10 October 2019
      • Bioethics Issues in Somatic and Germline Gene Editing: Key Content
    • GE2P2 Global Foundation – Board Documentation
    • ICGEN :: Life Cycle Documentation
    • requiem for integrity :: Project Content Repository
      • Lullabies and Cradle Songs
    • Contracts/Concept Notes/RFP-Bid Responses Repository
      • OSIC
    • Advisors
      • Art Caplan
      • Anne Cropp
      • Lisa Kearns
      • Alison Bateman-House
      • JRT
      • Barbara Redman
      • Tom Watson
    • Center for Informed Consent Integrity Call Log
    • Fundraising 990 Respository
    • Patients, Politics, Pressure :: Pharma Stays Steady [Mostly] In Russia Sanctions Context
  • Global Forum for Research Ethics & Integrity [GFREI]
  • Public Consultation/Public Comment Watch
  • Community of Practice
  • GE2P2 Global Advisory Services pbc
    • Bioethics Program – Initiative 2.0
      • Bioethics Initiative 10.0
        • Advisory Case Documentation :: IBAC
      • Bioethics Initiative 11.0
      • Bioethics Initiative 13.0
      • Bioethics Initiative 6.0
      • Bioethics Initiative 7.0
      • Bioethics Initiative 8.0
    • IBAC Advisory Program – Initiative 1.0
      • GE2P2 Global – Initiative 4.0
        • GFREI Content
      • Initiative 1.0 :: Key Work Products
    • Initiative File 3.0
      • RFPS-NYH-2019-503076
    • Bioethics Initiative 12.0
      • Case Documentation
    • GE2P2 Global Advisory Services pbc_Board Documentation
    • OSIC Project Page
    • Advisory Case :: 2020-F
    • Bioethics Initiative 5.0
  • Contact

Bioethics Initiative 11.0

GSK – Compassionate Use Policy Development [Feb, 2020]

Key Documentation

Program Case Cover Sheet :: GSK-GE2P2 IBAC_Program Case Cover Sheet_Treatment Use Policy advice

GSK PPT Case Overview/IBAC Call of 14 Feb 2020 ::  GSK_EA Policy Case_Jan 2020_Treatment Use of Unapproved Medicines

GSK CU Policy [at Feb 2020] :: GSK_EAP Policy Case_POL_87186 DRAFT v8 (002)AF

GSK SOPs [at Feb 2020]
GSK_Importation SOP_2018_00000631294
GSK_CU SOP_2018_00000454971

Blog at WordPress.com.
  • Follow Following
    • GE2P2 Global :: Knowledge Sharing; Ideas; Operations
      • Join 31 other followers
    • Already have a WordPress.com account? Log in now.
    • GE2P2 Global :: Knowledge Sharing; Ideas; Operations
    • Customize
    • Follow Following
    • Sign up
    • Log in
    • Copy shortlink
    • Report this content
    • View post in Reader
    • Manage subscriptions
    • Collapse this bar